Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Screening and treatment practices for tuberculosis infection in Nordic, Baltic and Central European countries and Ukraine in 2023.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Same author

High-Flow Oxygen Therapy vs. Continuous Positive Airway Pressure in Hospitalised Bronchiolitis: A Meta-Analysis.

Acta paediatrica (Oslo, Norway : 1992)·2025

Same author

Guidelines for children's lower respiratory infections stress both implementation and de-implementation.

Acta paediatrica (Oslo, Norway : 1992)·2024

Same author

Residential Area Characteristics Are Associated With Asthma Burden in Children.

Pediatric pulmonology·2024

Same author

Working group summary of the 2023 full update of the Finnish national guidelines for paediatric lower respiratory tract infections.

Acta paediatrica (Oslo, Norway : 1992)·2024

Same author

Genetic Susceptibility to Acute Viral Bronchiolitis.

The Journal of infectious diseases·2024

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of ¹⁸FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

[Infantile tuberculosis--to be considered again].

Pia Toikka¹, Merja Helminen, Iiris Rajalahti

¹TAYS:n lastenklinikka, PL 2000, 33521 Tampere.

Duodecim; Laaketieteellinen Aikakauskirja

|April 4, 2009

Summary

Finland stopped routine BCG newborn vaccination in 2006. A six-month-old infant developed tuberculosis despite not being in a risk group, highlighting potential gaps in targeted vaccination strategies.

Related Experiment Videos

Last Updated: Jun 24, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of ¹⁸FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

Pediatrics
Infectious Diseases
Public Health

Background:

Finland transitioned from universal newborn Bacillus Calmette-Guérin (BCG) vaccination to a targeted approach in August 2006.
The current strategy prioritizes BCG vaccination for children identified as having an increased risk of tuberculosis (TB) exposure.

Observation:

A six-month-old Finnish infant was diagnosed with pulmonary tuberculosis.
The infant did not belong to any recognized risk group and had not received the BCG vaccine as a newborn.

Findings:

Despite extensive investigations, the source of the infant's tuberculosis infection could not be identified.
This case represents a potential gap in the current targeted BCG vaccination policy.

Implications:

The findings suggest that targeted BCG vaccination may not fully capture all infants at risk for TB.
Further evaluation of TB transmission dynamics in young children and the effectiveness of current risk stratification is warranted.
This case underscores the importance of considering TB in unvaccinated infants, even in low-prevalence settings.